PepGen Share Price

PepGen Share Price

NASDAQ: PEPG | Micro Cap | Healthcare
$3.93
+$0.10 (2.75%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

PepGen Stock Performance

Open
$3.93
Prev. Close
$3.83
Circuit Range
N/A
Day Range
$3.92 - $4.30
Year Range
$1.31 - $7.79
Volume
1,17,311
Average Traded
$4.11

PepGen Share Price Today

As of 20 November 2026, PepGen Inc.'s share price is $3.93. The stock opened at $3.93, compared to its previous close of $3.83. During today's trading session, PepGen Inc.'s share price traded between $3.92 and $4.30, with an average price of $4.11. Over the past 52 weeks, the stock has recorded a high of $7.79 and a low of $1.31. In terms of performance, PepGen Inc.'s share price has risen by 160.26% over the last six months and is down 38.79% on a year-on-year basis.

PepGen Share Price Chart

Line chart of the PepGen price trend over the selected period. The price rose overall, ranging from 3.75 to 4.18, ending at 3.83.
$3.92$4.30
L
Show Current Price
H

PepGen Stock Fundamentals & Key Indicators

Market Cap
$165.93M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.06
Revenue (TTM)
$0.00
Return On Equity (TTM)
-71.13%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-5.73%

PepGen Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.34-$17.76-$17.81-$19.39
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A3.16%-0.28%-8.87%

PepGen Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$69.10-$78.63-$89.98-$89.66
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.79%-14.43%0.36%

PepGen Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets22.9427.1230.3731.36
Current Assets150.96123.76112.68186.08
Total Assets173.91150.88143.05217.44
Non Current Liabilities13.8215.5717.118.98
Current Liabilities12.6516.717.5318.83
Total Liabilities26.4632.2634.6337.81
Shareholders' Equity147.44118.62108.42179.63

PepGen Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-81.64-82.37-69.0-59.27
Investing-15.24-37.67-32.0-3.76
Financing107.9888.75-0.19112.19

About PepGen

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

PepGen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.40
$3.92
+67.02%
Oct 2026
$2.38
$2.35
-2.69%
Sep 2026
$2.98
$2.42
-21.59%
Aug 2026
$1.78
$3.08
+74.01%
Jul 2026
$1.80
$1.77
-1.39%
Jun 2026
$1.47
$1.79
+18.87%
May 2026
$1.65
$1.51
-8.21%
Apr 2026
$1.76
$1.65
-5.73%
Mar 2026
$6.02
$1.75
-71.90%
Feb 2026
$5.15
$6.21
+21.29%
Jan 2026
$6.40
$5.12
-21.59%
Dec 2025
$6.24
$6.53
+1.71%

PepGen Share Price FAQs